InvestorsHub Logo

H1C

06/01/20 4:39 PM

#15098 RE: locicat1 #15096

Yes you're right. I misremembered: the FDA seemingly all but invited them to revise and submit a proposal for a phase 3 trial, with the strong suggestion that it would be approved.

https://www.immunetherapeutics.com/2018/03/immune_therapeutics_inc_received_minutes_from_fda_meeting_for_lodonal_for_the_treatment_for_crohns_disease/